- Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 416 publications
- Percutaneous Coronary Intervention , 211 publications
- Clopidogrel , 189 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
- Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- N/A
- Sexes
- All
My publications
Filter publications
844 publications
2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
鈥�2025
1-Month or 3-Month DAPT in Women and聽Men at High Bleeding Risk Undergoing PCI.
JACC. Cardiovascular interventions
鈥�2025
Predictive Value of Platelet Fc纬RIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction
Circulation: Cardiovascular Interventions
2025
Editorial: Navigating the complexity of bleeding and hypercoagulable disorders in patients with acute myocardial infarction
Cardiovascular Revascularization Medicine
2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Nature Reviews Cardiology